Agentes inmunomoduladores (IMiDs): herramientas para el tratamiento del mieloma múltiple
Thalidomide changed the treatment of patients with multiple myeloma, however, its effectiveness has been compromised due to its side effects. New strategies are needed to specifically target the challenges of multiple myeloma through innovative, more effective, and less toxic therapy. The new immuno...
Enregistré dans:
| Auteurs principaux: | , , , |
|---|---|
| Langue: | Spanish / Castilian |
| Publié: |
Sociedad Médica de Santiago
2018
|
| Sujets: | |
| Accès en ligne: | http://www.scielo.cl/scielo.php?script=sci_arttext&pid=S0034-98872018001201444 |
| Tags: |
Ajouter un tag
Pas de tags, Soyez le premier à ajouter un tag!
|